Top of the Street: Exor, STMicroelectronics, Klepierre, Roche, Maersk
11/10/2022 13:54
A round-up of notable broker activity this morning from Europe's
top-ranked* analysts:
INITIATIONS AND REINSTATEMENTS
** Exane BNP Paribas initiates Exor EXOR.AS with a
"neutral" rating and EUR 75 target price, saying the risk-reward
seems balanced for the holding company of Italy's Agnelli family
** Citi adds "buy"-rated STMicroelectronics STM.PA to its
European Focus List, saying the Franco-Italian chipmaker's
end-market and customer exposures make it more resilient than
peers
** Citi also adds "sell"-rated French mall owner Klepierre
LOIM.PA to the list, as possible profitability issues for some
tenants could make it harder for the group to raise rents
** Another stock added to Citi's focus list is Swiss pharma
group Roche, rated "buy", with the broker flagging a "highly
attractive risk-reward" at current valuation
** Citi also adds "sell"-rated shipping giant Maersk
MAERSKb.CO to the list, and removes "buy"-rated Entain
ENT.L , Haleon HLN.L , Arcelormittal MT.LU , Umicore UMI.BR
and Capgemini CAPP.PA , and "sell"-rated Orsted ORSTED.CO
(*Analyst rankings from Thomson Reuters StarMine. The scale is
from 1-star to 5-star with 5 being the best. Analysts are ranked
on earnings accuracy as well as relative performance of
recommendations over trailing 12-month & 24-month periods.)
(Reporting by Federica Mileo and Flora Gomez in Gdansk)
((Federica.mileo@thomsonreuters.com
Flora.gomez@thomsonreuters.com))